Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1200/jco.20.01632
PubMed Identifier: 33119479
Publication URI: http://europepmc.org/abstract/MED/33119479
Type: Journal Article/Review
Volume: 39
Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Issue: 1
ISSN: 0732-183X